GlassScriptPhysician profile
Srikanth Malempati
NPI 1730284456
$1,629.10
in general payments reported to CMS, 2019-2025
28 companies · $37.70 in 2025
The $37.70 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $150 · 2021: $167 · 2022: $97.75 · 2023: $39.13 · 2024: $219 · 2025: $37.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $363.04 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $234.67 | 2019-2024 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.79 | 2019-2021 | |
| Amarin Pharma, INC. | $154.06 | 2019-2021 | |
| Amgen INC. | $117.11 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $72.88 | 2019 | |
| Novo Nordisk INC | $70.13 | 2019-2021 | |
| Pfizer INC. | $65.03 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.19 | 2024 | |
| Janssen Pharmaceuticals, INC | $51.72 | 2019 | |
| Bausch Health US, LLC | $45.00 | 2021 | |
| Smith+Nephew, INC. | $38.49 | 2019 | |
| Lilly USA, LLC | $33.12 | 2020-2022 | |
| Astellas Pharma US INC | $24.10 | 2019 | |
| Renalytix Ai, INC. | $22.90 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $22.82 | 2025 | Cologuard Collection Kit |
| Si-Bone, INC. | $21.25 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $15.38 | 2019 | |
| Dexcom, INC. | $14.42 | 2024 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $14.11 | 2019 | |
| Fidia Pharma USA INC. | $8.89 | 2020 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Malempati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.